BIOX - CIK 0001769484
The table below shows Bioceres Crop Solutions Corp.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | $26.65M | $36.30M | $23.85M | $41.54M | $37.49M | $42.64M |
| R&D | $2.35M | $5.72M | $3.66M | $1.97M | $4.41M | $3.59M |
| SG&A |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $17.14M |
| $23.14M |
| $26.15M |
| $25.35M |
| $30.16M |
| $27.09M |
| Operating income | - | - | - | - | - | - |
| Income tax | - | - | - | - | - | - |
| Net income | - | - | - | - | - | - |
| EPS (diluted) | - | - | - | - | - | - |